-
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
Post on 1/20/21
-
Where Will Pfizer Be in 5 Years?
Post on 1/20/21
-
Ortho Clinical Diagnostics Launch of IPO
Post on 1/19/21
-
Signet Healthcare and Bionpharma Sell CoreRx
Post on 1/19/21
-
Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences
Post on 1/19/21
-
Better Choice Company Closes Strategic Investment of $2.7 Million
Post on 1/19/21
-
Minerva Neurosciences and Royalty Pharma Announce Sale of Seltorexant Royalty for up to $155 Million
Post on 1/19/21
-
Can the Pfizer and Moderna Vaccines Beat the New Coronavirus Strains?
Post on 1/19/21
-
Is Pfizer Stock a Buy?
Post on 1/19/21
-
Should You Buy Johnson & Johnson For Its COVID Vaccine?
Post on 1/19/21
-
ProPhase Labs Prices of Public Offering of Common Stock
Post on 1/18/21
-
ProPhase Labs Proposes Public Offering of Common Stock
Post on 1/16/21
-
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Post on 1/15/21
-
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
Post on 1/15/21
-
KidsX Selects 13 Startups for Inaugural Cohort
Post on 1/14/21
-
Provention Bio Prices $100M Public Offering of Common Stock
Post on 1/13/21
-
Applied DNA Closes of $15 Million Registered Direct Offering
Post on 1/13/21
-
Columbia Care Closes of Public Offering
Post on 1/13/21
-
Rose Health Announces Oversubscribed Seed Round
Post on 1/12/21
-
Solaris Health Partners With MidLantic Urology Partners
Post on 1/12/21
-
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock
Post on 1/12/21
-
Better Choice Secures $12.0 Million Credit Facility
Post on 1/12/21
-
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
Post on 1/12/21
-
electroCore Provides Business Update and Select Financial Guidance
Post on 1/12/21
-
Amneal to Acquire Kashiv Specialty Pharmaceuticals
Post on 1/12/21